| 27/01 | FDA advisers back the same COVID vaccine for initial shots, boosters |  |
| 26/01 | Novavax busca un período de 6 meses para producir vacunas COVID que coincidan con las n.. |  |
| 26/01 | Novavax needs 6 months to produce annual COVID shots that match new variants | |
| 25/01 | Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) | |
| 20/01 | River Private Wealth announces new round of investment in Novavax, Inc | |
| 20/01 | Novavax, Inc. announced that it has received $6.75 million in funding from River Privat.. | |
| 18/01 | Novavax Says South Korea Partner Obtained Approval for Use of COVID-19 Vaccine as Adult.. | |
| 18/01 | Novavax COVID-19 Jab Gets South Korea's OK as Booster for Adults | |
| 18/01 | Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster | |
| 13/01 | ANALYSEN DES TAGES von Dow Jones Newswires (13.01.2023) |  |
| 10/01 | Presse Rundblick - Dienstag, 10. Januar | |
| 10/01 | 4 minutos de mercados del martes 10 de enero | |
| 10/01 | Cronache di Borsa - Martedì 10 gennaio |  |
| 10/01 | MarketScreener's World Press Review: January 10 | |
| 10/01 | North American Morning Briefing: More Hawkish Fed -2- | |
| 09/01 | Novavax's longtime CEO Stanley Erck to retire | |
| 09/01 | Novavax Appoints John Jacobs as CEO | |
| 09/01 | Novavax's longtime CEO Stanley Erck to retire | |
| 09/01 | Novavax Inc : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi.. | |
| 09/01 | Novavax Names John C. Jacobs as New President & Chief Executive Officer | |
| 09/01 | Novavax, Inc. Announces Management Changes | |
| 09/01 | Novavax, Inc. Announces Chief Executive Officer Changes | |
| 09/01 | Novavax CEO Stanley Erck to retire | |
| 09/01 | Novavax : to Participate in the 41st Annual J.P. Morgan Healthcare Conference | |
| 2022 | Novavax Initiates Phase 2 Trial for COVID-19-Influenza Combination, Stand-Alone Influen.. | |
| 2022 | Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and St.. | |
| 2022 | Novavax, Inc. Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination .. | |
| 2022 | Novavax Completes Offerings of Common Shares, Convertible Notes for Gross Proceeds of $.. | |
| 2022 | Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O.. | |
| 2022 | Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2.. | |
| 2022 | Dow Jones Industrial : Todo en short: los vendedores en corto ganar.. | |
| 2022 | Analysis-Short sellers gain nearly $304 billion after tumble in U.S. stocks | |
| 2022 | Novavax to Start Influenza's Phase 2 CIC Trial by 2022 End | |
| 2022 | Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O.. | |
| 2022 | Novavax Inc : Entry into a Material Definitive Agreement, Other Events, Financial Statemen.. | |
| 2022 | German Health Authority Expands Recommendation for Use of Novavax COVID-19 Vaccine as a.. | |
| 2022 | Novavax Receives Expanded Recommendation For COVID-19 Vaccine From Germany | |
| 2022 | Sector Update: Health Care Stocks Stumble on Friday | |
| 2022 | Sector Update: Health Care Stocks Lose Ground in Friday Trading | |
| 2022 | Sector Update: Health Care | |
| 2022 | Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Offi.. | |
| 2022 | Sector Update: Health Care Stocks Mixed Premarket Friday | |
| 2022 | Weak Retail Spending, Recession Fears Expected to Continue Weighing on US Equities | |
| 2022 | Sector Update: Health Care | |
| 2022 | Novavax Prices $150 Million Senior Notes Offering, $65 Million Common Stock Offering | |
| 2022 | MORNING BRIEFING - USA/Asien | |
| 2022 | MORNING BRIEFING - Deutschland/Europa | |
| 2022 | Novavax Announces Pricing of $65 Million Public Offering of Common Stock | |
| 2022 | Novavax Announces Pricing of $65 Million Public Offering of Common Stock | |
| 2022 | Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes | |
| 2022 | Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes | |
| 2022 | Novavax's Shares Drop 37% After Cut In COVID-19 Vaccine Supplies To UK | |
| 2022 | Aktien New York Schluss: Heftige Verluste - Frust wegen Fed hält.. | |
| 2022 | Nordson, AbCellera rise; Warner Bros., Novavax fall | |
| 2022 | MÄRKTE USA/Zins- und Rezessionsängste schicken Aktien auf Talfahrt | |
| 2022 | Aktien New York: Indizes weiten heftige Verluste wegen US-Geldpolitik no.. | |
| 2022 | Top Midday Decliners | |
| 2022 | Novavax Down 26% After Announcing Stock and Convertible Note Sales | |
| 2022 | MÄRKTE USA/Zinsängste schicken Aktien auf Talfahrt | |
| 2022 | Aktien New York Eröffnung: Weitere klare Verluste wegen US-Gel.. | |
| 2022 | Global markets live: HSBC, Tesla, Microsoft, Blackstone, Serco... | |
| 2022 | MÄRKTE USA/Weiter abwärts nach Fed-Aussagen | |
| 2022 | No Christmas rally this year? | |
| 2022 | Sector Update: Health Care Stocks Mixed Premarket Thursday | |
| 2022 | MÄRKTE USA/Weiter abwärts nach Fed-Aussagen - Tesla schwach erwartet | |
| 2022 | Aktien New York Ausblick: Weitere Verluste - Enttäuschung über .. | |
| 2022 | North American Morning Briefing: Rough Start For Futures.. | |
| 2022 | MARKT USA/Weiter abwärts nach Fed-Aussagen - Tesla schwach erwartet | |
| 2022 | Novavax Inc : Regulation FD Disclosure, Other Events (form 8-K) | |
| 2022 | Novavax, Inc. Reaffirms Revenue Guidance for the Full Year 2022 | |
| 2022 | Novavax Plans $125 Million Common-Stock Offering, $125 Million Debt Offering; Shares De.. | |
| 2022 | Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes | |
| 2022 | Novavax Announces Proposed $125 Million Public Offering of Common Stock | |
| 2022 | Novavax Secures Expanded Use for COVID-19 Booster in Switzerland, France | |
| 2022 | Novavax : Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid .. | |
| 2022 | NOVAVAX INC Change in Directors or Principal Officers (form 8-K/A) | |
| 2022 | Novavax, Inc. Appoints Richard J. Rodgers as Member of Its Audit Committee and as A Mem.. | |
| 2022 | French Public Health Body Snubs Valneva in COVID-19 Vaccine Strategy | |
| 2022 | Valneva shares fall as French health body advises against its COVID-19 vaccine | |
| 2022 | Novavax's COVID-19 Jab Gets Canadian Approval for Adolescents | |
| 2022 | Novavax Covid-19 Vaccine Gets Health Canada Approval for Adolescents | |
| 2022 | Novavax Says Canadian Regulator Approves Nuvaxovid COVID-19 Vaccine for Adolescents | |
| 2022 | Canada OKs Novavax's Covid Vaccine for Adolescents Aged 12-17 | |
| 2022 | Novavax, Inc. Announces Nuvaxovid COVID-19 Vaccine Approval in Canada for Use as a Prim.. | |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Ad.. | |
| 2022 | Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference | |
| 2022 | Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference | |
| 2022 | TRADING UPDATES: XLMedia, Mobile Streams and Windar win deals | |
| 2022 | Novavax Says WHO Updates Emergency Use Listing for Its COVID-19 Vaccine | |
| 2022 | World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 .. | |
| 2022 | Novavax, Inc. Announces the World Health Organization Issue an Updated Emergency Use Li.. | |
| 2022 | Novavax - Termination of COVID-19 Vaccine Purchase Agreement with Gavi | |
| 2022 | GAVI Alliance Refutes Novavax's Claims Of Breaching COVID-19 Vaccine Purchase Deal | |
| 2022 | Gavi rejects Novavax's claim on COVID vaccine deal breach | |
| 2022 | Gavi says it is not in breach of Novavax vaccine deal | |
| 2022 | Novavax Ends COVID-19 Vaccine Purchase Agreement With the Gavi Alliance | |
| 2022 | Novavax Ends COVID-19 Vaccine Purchase Deal With GAVI Amid Material Breach | |
| 2022 | Novavax ends COVID vaccine sale agreement with Gavi | |
| 2022 | Novavax ends COVID vaccine sale agreement with Gavi | |
| 2022 | Novavax Inc : Termination of a Material Definitive Agreement (form 8-K) | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
